Moreover, in other forms of CKD, including lupus nephritis (36), IgA nephropathy (34), and end-stage kidney disease dialysis patients (35), increased LRG1 plasma and biopsy tissue levels correlate with worse outcome, increased inflammatory markers, and greater fibrosis. Here, LRG1 is linked to chronic kidney disease.